Loading company…
Shanwan Biotech develops sustained-release injectable drugs and provides pharmaceutical CDMO services.
Shanwan Biotech develops and manufactures sustained-release injectable formulations using in-situ gel technology. It also provides contract development and manufacturing services to pharmaceutical companies. Founded in 2018, it is based in Suzhou, China, and closed Series B funding from Jiangsu Jinqiao Private Equity Fund Management in April 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in